Abstract:Background: Maternal depression is a serious condition that affects up to 1 in 7 pregnancies. Despite evidence linking maternal depression to pregnancy complications and adverse fetal outcomes, there remain large gaps in its identification and treatment. More work is needed to define the specific timing and severity of depression that most urgently requires intervention, where feasible, to protect maternal health and the developing fetus. Objective: This study aimed to examine whether the timing and severity of maternal depression and/or anxiety during pregnancy affect child executive functioning at age 4.5 years. Executive functioning in the preschool years is a strong predictor of both school readiness and long-term quality of life. Study design: This longitudinal observational pregnancy cohort study included a sample of 323 mother-child dyads taking part in the Ontario Birth Study, an open pregnancy cohort in Toronto, Ontario, Canada. Maternal symptoms of depression and anxiety were assessed at 12 to 16 and 28 to 32 weeks of gestation and at the time of child testing at age 4.5 years using the 4-item Patient Health Questionnaire. Child executive functioning was measured during a home visit using standardized computerized administration of the Flanker test (a measure of attention) and the Dimensional Change Card Sort (a measure of cognitive flexibility). Stepwise linear regressions, controlling for possible confounding variables, were used to assess the predictive value of continuous measures of maternal depression and/or anxiety symptoms at each assessment time on the Flanker test and Dimensional Change Card Sort. Posthoc general linear models were used to assess whether maternal depression severity categories (no symptom, mild symptoms, or probable major depressive disorder) were helpful in identifying children at risk. Results: Across all children, after controlling for potential confounds, greater maternal depressive symptoms at weeks 12 to 16 weeks of gestation predicted worse performance on both the Flanker test (ΔR2=0.058; P<.001) and the Dimensional Change Card Sort (ΔR2=0.017; P=.018). Posthoc general linear modeling further demonstrated that the children of mothers meeting the screening criteria for major depression in early pregnancy scored 11.3% lower on the Flanker test and 9.8% lower on the Dimensional Change Card Sort than the children of mothers without maternal depressive symptoms in early pregnancy. Mild depressive symptoms had no significant effect on executive function scores. There was no significant effect of anxiety symptoms or maternal antidepressant use in early pregnancy or pandemic conditions or maternal symptoms in later pregnancy or at the time of child testing on either the Flanker or Dimensional Change Card Sort results. Conclusion: This study demonstrated that fetal exposure to maternal major depression, but not milder forms of depression, at 12 to 16 weeks of gestation is associated with impaired executive functioning in the preschool years. Child executive functioning is crucial for school readiness and predicts long-term quality of life. This emphasizes an urgent need to improve the recognition and treatment of maternal major depression, particularly in early pregnancy, to limit its negative effects on the patient and on child cognitive development.

The association between perinatal depressive symptoms and child neurodevelopment

The Effects of Maternal Perinatal Depression on Child IQ: A Systematic Review

Perinatal depression and children's developmental outcomes at 2 years postpartum

Association Between Perinatal Depression and Risk of Attention Deficit Hyperactivity Disorder among Children: a Retrospective Cohort Study

Association of Mild Iodine Insufficiency during Pregnancy with Child Neurodevelopment in Patients with Subclinical Hypothyroidism or Hypothyroxinemia

Associations between maternal prenatal depression and neonatal behavior and brain function – Evidence from the functional near-infrared spectroscopy

- Infant Development as the link between Antenatal Psychopathology and Offspring Outcomes

Associations between maternal depression trajectories and infant neurodevelopment at eight months

Effects of Antenatal Maternal Depressive Symptoms and Socio-Economic Status on Neonatal Brain Development are Modulated by Genetic Risk

Association of Maternal Mild Hypothyroidism with Offspring Neurodevelopment in TPOAb-Negative Women: A Prospective Cohort Study.

Perinatal Depression and Infant and Toddler Neurodevelopment: A Systematic Review and Meta-Analysis.

Associations between antenatal depressive symptoms in different trimesters and perinatal outcomes: A prospective multicenter cohort study in China

Maternal Mental Health in Pregnancy and Its Impact on Children's Cognitive Development at 18 Months, during the COVID-19 Pandemic (CONCEPTION Study)

Maternal Thyroid Dysfunction and Neuropsychological Development in Children

Abnormalities of Maternal Thyroid Function During Pregnancy Affect Neuropsychological Development of Their Children at 25–30 Months

Neonatal Outcomes in Women With Untreated Antenatal Depression Compared With Women Without Depression: A Systematic Review and Meta-analysis

The Impact of Perinatal Depression on Children’s Social-Emotional Development: A Longitudinal Study

Maternal major depression during early pregnancy is associated with impaired child executive functioning at 4.5 years of age

Maternal postnatal depressive symptoms and early achievement of developmental milestones in infants and young children: A meta‐analysis

Associations Between Antenatal Corticosteroid Exposure and Neurodevelopment in Infants

Association Between Maternal Depression and Neonatal Outcomes: Evidence from a Survey of Nationally Representative Longitudinal Studies.